Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
XBP - XBP Europe Holdings Inc - Stock Price Chart
TickerXBP [NASD]
CompanyXBP Europe Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap65.77MEPS (ttm)-2.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-7853.04%
Dividend-Sales Q/Q-
Insider Own72.32%Inst Own22.24%
Insider Trans-0.46%Inst Trans-68.24%
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume29.85K52W Range1.14 - 47.40
Today 08:30AM XBP Europe Awarded a Transformation Project for His Majesty's Passport Office (HMPO) (GlobeNewswire) +66.41%
Apr-01-24 05:00PM XBP Europe Holdings, Inc. Reports Full Year 2023 Results (GlobeNewswire)
Jan-23-24 08:30AM Exela Technologies and XBP Europe Announce the Launch of Reaktr.ai to Provide Cybersecurity, Data Modernization and Multi-Cloud Management Enabled by AI (GlobeNewswire) -7.14%
Jan-03-24 11:25AM XBP Europe to Ring Nasdaq Opening Bell on January 5, 2024 (GlobeNewswire)
CNTX - Context Therapeutics Inc - Stock Price Chart
TickerCNTX [NASD]
CompanyContext Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap27.95MEPS (ttm)-1.50
P/E-EPS this Y13.67%
Forward P/E-EPS next Y10.42%
PEG-EPS past 5Y-26.70%
P/S-EPS next 5Y-
P/B2.35EPS Q/Q-90.31%
Dividend-Sales Q/Q-
Insider Own12.06%Inst Own18.65%
Insider Trans0.00%Inst Trans4.15%
Short Float0.29%EarningsMar 21/b
Analyst Recom1.00Target Price4.00
Avg Volume57.03K52W Range0.47 - 1.69
Today 07:31AM Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 (GlobeNewswire) +28.68%
07:30AM Context Therapeutics Announces $100 Million Private Placement (GlobeNewswire)
Apr-01-24 07:30AM Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers (GlobeNewswire)
Mar-21-24 01:53PM CNTX Stock Earnings: Context Therapeutics Misses EPS for Q4 2023 (InvestorPlace) -6.96%
07:43AM Context Therapeutics Reports Full Year 2023 Operating and Financial Results (GlobeNewswire)
Nov-09-23 04:15PM Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results (GlobeNewswire)
Oct-31-23 09:00AM Context Therapeutics Announces Preclinical Data Demonstrating Differentiated and Active Profile of its Claudin 6-Targeted Bispecific Antibody CTIM-76 (GlobeNewswire)
Oct-24-23 12:30PM 10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis (ACCESSWIRE) +13.64%
Sep-27-23 09:00AM Context Therapeutics Announces Acceptance of Abstract to be Presented at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting (GlobeNewswire) +16.22%
Aug-10-23 02:19PM Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update (News Direct) +10.64%
ASNS - Actelis Networks Inc - Stock Price Chart
TickerASNS [NASD]
CompanyActelis Networks Inc
CountryUSA
IndustryCommunication Equipment
Market Cap1.81MEPS (ttm)-2.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.32EPS next 5Y-
P/B7.88EPS Q/Q52.85%
Dividend-Sales Q/Q-59.87%
Insider Own11.58%Inst Own11.14%
Insider Trans-0.06%Inst Trans-56.99%
Short Float0.40%EarningsMar 26/a
Analyst Recom-Target Price-
Avg Volume12.62K52W Range0.62 - 11.26
Today 08:37AM Actelis Receives $2.3 Million Order for Immediate Delivery of New Hybrid-Fiber Intelligent Networking Solution For Washington D.C.'s Department of Transportation (GlobeNewswire) -24.04%
Apr-04-24 08:30AM Actelis Networks and Khushi Communications Partner to Enable Expansion of IoT Networks Throughout India (GlobeNewswire) +5.13%
Mar-26-24 10:53PM ASNS Stock Earnings: Actelis Networks Reported Results for Q4 2023 (InvestorPlace)
04:30PM Actelis Networks Reports Fiscal Full Year 2023 Results (GlobeNewswire)
Mar-12-24 08:30AM Actelis Networks and Netceed Sign Partnership Agreement to Extend Actelis' Hybrid-Fiber Networking Solutions to Netceed's North American Customer Base (GlobeNewswire)
Feb-29-24 08:30AM Actelis Achieves National Institute of Standards and Technology (NIST) Certification for Data Cyber Security (GlobeNewswire) -5.22%
Feb-07-24 04:30PM Actelis Networks Announces New $1.5 Million Credit Line (GlobeNewswire)
Feb-01-24 08:30AM Actelis Receives Order For City of Napa Intelligent Traffic Management System (GlobeNewswire)
Jan-16-24 08:30AM Actelis Announces U.S. Department of Defense JITC Labs Approval for Cybersecurity and Interoperability and Approved Products List Status (GlobeNewswire)
Dec-28-23 08:30AM Actelis Receives Order From Major North American Rail Operator For Management Software And Services (GlobeNewswire)
IBAC - IB Acquisition Corp. - Stock Price Chart
TickerIBAC [NASD]
CompanyIB Acquisition Corp.
CountryUSA
IndustryShell Companies
Market Cap136.44MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.75K52W Range9.96 - 9.98
ALLR - Allarity Therapeutics Inc - Stock Price Chart
TickerALLR [NASD]
CompanyAllarity Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap0.58MEPS (ttm)-4117.54
P/E-EPS this Y86.06%
Forward P/E-EPS next Y-6.29%
PEG-EPS past 5Y57.56%
P/S-EPS next 5Y-
P/B-EPS Q/Q99.91%
Dividend-Sales Q/Q-
Insider Own10.59%Inst Own0.62%
Insider Trans0.00%Inst Trans-
Short Float25.01%EarningsMar 08/b
Analyst Recom1.00Target Price8.00
Avg Volume549.99K52W Range1.15 - 372.00
Today 11:27AM JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock (InvestorPlace) -10.22%
11:13AM Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts (InvestorPlace)
08:00AM Allarity Therapeutics' Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer (GlobeNewswire)
Apr-29-24 07:00AM Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement (GlobeNewswire) -5.48%
Apr-17-24 09:10AM Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1) (GlobeNewswire) -10.71%
Apr-12-24 08:18AM Why Is Allarity Therapeutics (ALLR) Stock Up 41% Today? (InvestorPlace) -8.58%
Apr-04-24 09:15AM Allarity Therapeutics Announces 1-for-20 Reverse Stock Split (GlobeNewswire) +5.78%
Mar-27-24 08:30AM Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer (GlobeNewswire)
Mar-25-24 07:30AM Allarity Therapeutics Receives Extension from Nasdaq Hearings Panel to Regain Compliance with Listing Rules 5550(a)(2) and 5550(b)(1) (GlobeNewswire) -12.25%
Mar-08-24 07:15AM Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update (GlobeNewswire)
EWK - iShares MSCI Belgium ETF - Stock Price Chart
TickerEWK [NYSE]
CompanyiShares MSCI Belgium ETF
CountryUSA
IndustryExchange Traded Fund
CategoryGlobal or ExUS Equities - Country Specific
IndexMSCI Belgium IMI 25/50 Index
TagsBelgium, equity
Sector/Theme Region
Dividend2.09%Active/Passive
Total Holdings43AUM20.77M
Flows% 1M0.00%Flows% 3M16.13%
Flows% YTD16.13%Flows% 1Y
Return% 1Y-1.45%Return% 3Y-0.03%
Return% 5Y2.02%Return% 10Y
NAV% Expense
Avg Volume4.28K52W Range16.17 - 19.31
Mar-04-19 08:22AM 3 Europe ETFs Breaking Out Ahead of Brexit Deadline (Investopedia)
Mar-01-19 02:49PM Belgium ETF Cheers on Anheuser-Busch InBevs Optimistic Outlook (ETF Trends)
Aug-02-18 01:30PM Eurozone Slows Down in Q2, Puts These Country ETFs in Focus (Zacks)
Jul-10-18 08:00AM 2018 World Cup Semi-Finals: ETF Version (Zacks)
Jun-21-18 10:25AM These 3 European Nations Could Lead the Way Lower (Investopedia)
Jul-10-17 03:48PM Will Top ETF Areas of 1H Carry Momentum in 2H? (Zacks)
Jun-09-17 09:30AM The Zacks Analyst Blog Highlights: iShares MSCI Austria Capped, iShares MSCI Netherlands, iShares MSCI Sweden Capped, iShares MSCI Ireland Capped, iShares MSCI Belgium Capped and First Trust Switzerland AlphaDEX ETF (Zacks)
Jun-08-17 10:52AM 6 European Country ETFs to Buy Now (Zacks)
Jul-18-16 12:19PM Will the Brexit Vote Benefit the United Kingdom? (Market Realist)
Jun-29-16 07:28PM Europe After Brexit: 5 Keys to Investing with ETFs (Zacks)
SGBX - Safe & Green Holdings Corp - Stock Price Chart
TickerSGBX [NASD]
CompanySafe & Green Holdings Corp
CountryUSA
IndustryMetal Fabrication
Market Cap53.27MEPS (ttm)-1.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y20.38%
P/S2.85EPS next 5Y-
P/B8.49EPS Q/Q-23.26%
Dividend-Sales Q/Q-3.99%
Insider Own34.90%Inst Own3.48%
Insider Trans0.00%Inst Trans3.11%
Short Float0.11%EarningsApr 15/a
Analyst Recom1.00Target Price56.24
Avg Volume158.20K52W Range2.01 - 27.00
Today 08:30AM Safe and Green Holdings Announces Collaboration and Sales of Modular Units to Britten Inc. (GlobeNewswire) +32.94%
Apr-30-24 10:15AM Correction: Safe & Green Holdings Corp Announces Reverse Split of the Company's Common Stock (GlobeNewswire) -18.30%
09:28AM Safe & Green Holdings Corp Announces Reverse Split of the Company's Common Stock (GlobeNewswire)
Apr-25-24 09:00AM Safe & Green Holdings Announces it Has Entered Into an Agreement to Produce Four Modular Electrical Distribution Centers as Part of a Multi-Unit Order for a Client Serving the Big Box Retailer Market (GlobeNewswire) +51.98%
Apr-24-24 08:30AM Safe & Green Holdings Corp. Announces Receipt of Nasdaq Notification (GlobeNewswire)
Apr-19-24 09:00AM Safe & Green Holdings Corp Provides Update on Its Audit and Planned 10-K Filing for the Year Ended December 31, 2023 (GlobeNewswire)
Apr-15-24 04:05PM Safe & Green Holdings Corp to Report Financial Results and File Its Form 10-K for the Year Ended December 31, 2023, on April 16, 2024 (GlobeNewswire)
Apr-11-24 09:00AM Safe & Green Holdings Enters Design/build Agreement With Talent Services Llc for the Design and Production of Eight Units Currently in Concept Stage (GlobeNewswire)
Apr-04-24 04:05PM Safe & Green Holdings Corp to Report Financial Results and File Its Form 10-K for the Year Ended December 31, 2023, on April 15, 2024 (GlobeNewswire)
Mar-21-24 08:30AM Safe & Green Holdings Expands Contract with Government Contractor to Refurbish 19 Container Modules for a Major U.S. Agency (GlobeNewswire)
DIVZ - Opal Dividend Income ETF - Stock Price Chart
TickerDIVZ [NYSE]
CompanyOpal Dividend Income ETF
CountryUSA
IndustryExchange Traded Fund
CategoryUS Equities - Dividend & Fundamental
Index-
TagsU.S., equity, dividend, volatility
Sector/Theme Region
Dividend3.33%Active/Passive
Total Holdings30AUM64.26M
Flows% 1M-1.41%Flows% 3M0.00%
Flows% YTD-0.85%Flows% 1Y
Return% 1Y7.38%Return% 3Y0.04%
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume11.56K52W Range25.42 - 29.99
Mar-16-22 02:30PM NortonLifeLock Drops 12%; 206 ETFs Affected (ETF.com)
APVO - Aptevo Therapeutics Inc - Stock Price Chart
TickerAPVO [NASD]
CompanyAptevo Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.82MEPS (ttm)-72.07
P/E-EPS this Y-1223.51%
Forward P/E-EPS next Y59.98%
PEG-EPS past 5Y46.80%
P/S-EPS next 5Y-
P/B0.04EPS Q/Q57.76%
Dividend-Sales Q/Q-
Insider Own0.61%Inst Own2.75%
Insider Trans0.00%Inst Trans13.63%
Short Float9.10%EarningsMar 06/b
Analyst Recom1.00Target Price15.25
Avg Volume394.73K52W Range0.67 - 80.96
Today 07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +17.71%
Apr-16-24 12:47PM Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why (Zacks)
Apr-15-24 04:05PM Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering (ACCESSWIRE) -7.35%
Apr-11-24 08:15AM Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today? (InvestorPlace) -60.08%
08:00AM Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering (ACCESSWIRE)
Apr-10-24 09:00AM Aptevo Therapeutics Provides Pipeline Update (ACCESSWIRE) -26.38%
Mar-18-24 06:00AM Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference (ACCESSWIRE) -8.12%
Mar-07-24 08:55AM Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4 (ACCESSWIRE)
Mar-05-24 01:51PM APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q4 2023 (InvestorPlace) -8.55%
08:05AM Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update (ACCESSWIRE)
XBB - BondBloxx BB-Rated USD High Yield Corporate Bond ETF - Stock Price Chart
TickerXBB [NYSE]
CompanyBondBloxx BB-Rated USD High Yield Corporate Bond ETF
CountryUSA
IndustryExchange Traded Fund
CategoryBonds - Corporate
IndexICE BofA BB US Cash Pay High Yld Constra...
TagsU.S., bonds, corporate-bonds, high-yield
Sector/Theme Region
Dividend6.32%Active/Passive
Total Holdings917AUM57.12M
Flows% 1M0.00%Flows% 3M7.53%
Flows% YTD7.53%Flows% 1Y
Return% 1Y7.43%Return% 3Y-
Return% 5Y-Return% 10Y
NAV% Expense
Avg Volume1.44K52W Range37.28 - 40.65
123456⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.